Spots Global Cancer Trial Database for malignancy
Every month we try and update this database with for malignancy cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| International Prospective Registry of Disseminated Intravascular Coagulation | NCT03577015 | Disseminated In... | 18 Years - | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | ||
| Liquid Biopsy With Immunomagnetic Beads Capture Technique for Malignant Cell Detection in Body Fluid | NCT02891642 | Malignancy Pleural Effusio... Pleural Disease... Ascites | Immunomagnetic ... | 18 Years - 80 Years | The First Affiliated Hospital with Nanjing Medical University | |
| Phase 1 Trial of Intravenously Administered Nerofe™ in Subjects With Advanced Malignancies | NCT01690741 | Cancer | Nerofe | 18 Years - | Immune System Key Ltd | |
| Recurrence of Liver Malignancy After Ischemia/Reperfusion Injury | NCT04257240 | Ischemic Reperf... Liver Injury Cancer Recurren... Malignancy Liver Cancer | selective hepat... semielective he... | 18 Years - 90 Years | Aretaieion University Hospital | |
| Impact of Lifestyle Modification on the Development of Dementia, Chronic Kidney Disease, Diabetes, Chronic Obstructive Pulmonary Disease, Cancers and Cardiovascular Disease in a Thai General Population | NCT02967406 | Dementia Diabetes Mellit... Chronic Kidney ... Cardiovascular ... Malignancy Chronic Obstruc... | 4 x 4 lifestyle... | 45 Years - 75 Years | Sanpasitthiprasong Hospital | |
| Power Injectable Versus a Non-Power Injectable, Upper Arm, TIVAD for Chemotherapy | NCT02282449 | Malignancy | Power Injectabl... Non-Power Injec... | 16 Years - | University of Saskatchewan | |
| A Study of Gemcitabine and Demcizumab (OMP-21M18) With or Without Abraxane® as 1st-line Treatment in Subjects With Locally Advanced or Metastatic Pancreatic Cancer | NCT01189929 | Pancreatic Canc... | Demcizumab Abraxane® Gemcitabine | 21 Years - | Mereo BioPharma | |
| Allogeneic Hematopoietic Stem Cell Transplantation | NCT00750126 | Solid Tumors Hematologic Neo... | Fludarabine, Bu... | - 20 Years | University Hospital, Clermont-Ferrand | |
| Ultrasound Elastography of Breast Lesions | NCT00716482 | Breast Neoplasm... | 21 Years - | SuperSonic Imagine | ||
| Feasibility Study of Genomic Sequencing to Find Potential Targets for Personalized Therapy | NCT01869218 | Hematologic Neo... | 18 Years - | University of Colorado, Denver | ||
| A Phase 1 Dose Escalation Study of OMP-21M18 in Subjects With Solid Tumors | NCT00744562 | Solid Tumors | OMP-21M18 | 21 Years - | Mereo BioPharma | |
| ALM-488 for Intra-Operative Visualization of Nerves in Head and Neck Surgery | NCT05377554 | Surgery | ALM-488 Intraoperative ... Intra-operative... | 16 Years - | Alume Biosciences, Inc. | |
| Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory AML | NCT01191801 | Acute Myeloid L... | vosaroxin + cyt... placebo + cytar... | 18 Years - | Sunesis Pharmaceuticals | |
| A Study for Participants Previously Treated With Century Therapeutics Cellular Therapy Product | NCT05768269 | Hematological M... Solid Tumor Mal... | No Intervention | 18 Years - | Century Therapeutics, Inc. | |
| A Trial of AMXI-5001 for Treatment in Patients With Advanced Malignancies | NCT04503265 | Advanced Malign... Breast Cancer Ovarian Cancer Homologous Reco... Prostate Cancer Pancreatic Canc... | AMXI-5001:Dose ... AMXI-5001:Dose ... | 18 Years - | AtlasMedx, Incorporated | |
| Ultrasound-Guided Needle Biopsy in the Diagnosis of Malignant Cervical Lymphadenopathies | NCT01384357 | Lymphadenopathy Malignancy | 20 Years - 85 Years | Far Eastern Memorial Hospital | ||
| Carboplatin and Bevacizumab for Recurrent Ependymoma | NCT01295944 | Ependymoma Anaplastic Epen... | Carboplatin Bevacizumab | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| Tumor Monitoring Using Thermography During Radiation Therapy | NCT02776995 | Malignancy | Thermography im... | 18 Years - | Sheba Medical Center | |
| A Study of Carboplatin, Pemetrexed Plus Placebo vs Carboplatin, Pemetrexed Plus 1 or 2 Truncated Courses of Demcizumab in Subjects With Non-Squamous Non-Small Cell Lung Cancer | NCT02259582 | Nonsquamous Non... | Pemetrexed Carboplatin demcizumab | 21 Years - | Mereo BioPharma | |
| Thyroid Cancer in United Arab Emirates | NCT04763122 | Thyroid Cancer | not applicable ... | - | Tawam Hospital | |
| Performance of FISH for the Diagnosis of Malignant Biliary Strictures in Thai Patients | NCT02442167 | Bile Duct Stric... Malignancy | 18 Years - | Mayo Clinic | ||
| Treatment of Malignant Tumors With NK Cell | NCT05143125 | Malignancy | Decitabine comb... | 18 Years - 70 Years | Shenzhen University General Hospital | |
| Metabolic Changes in Patients With Chronic Cardiopulmonary Disease | NCT02550808 | Heart Failure Chronic Obstruc... Malignancy Chronic Kidney ... | 18 Years - | General and Teaching Hospital Celje | ||
| Malignancy Meta Analysis for BRL49653 | NCT01195259 | Diabetes Mellit... | allocation of t... | - | GlaxoSmithKline | |
| Individual Dietary Counseling Based on Taste-tests in Patients With Hematological Cancer in Cytostatic Therapy | NCT05364359 | Hematological M... | Taste-test Standard care | - | University of Copenhagen | |
| A Phase 1/2 Safety Study of Intratumorally Dosed INT230-6 | NCT03058289 | Breast Cancer Head and Neck C... Squamous Cell C... Lymphoma Pancreatic Canc... Liver Cancer Colon Cancer Lung Cancer Bile Duct Cance... Chordoma of Sac... Sarcoma | INT230-6 anti-PD-1 antib... anti-CTLA-4 ant... | 18 Years - | Intensity Therapeutics, Inc. | |
| Malignancy Meta Analysis for BRL49653 | NCT01195259 | Diabetes Mellit... | allocation of t... | - | GlaxoSmithKline | |
| Study of Voreloxin (Vosaroxin) in Older Patients With Untreated Acute Myeloid Leukemia | NCT00607997 | Leukemia Acute Disease Acute Myeloid L... Nonlymphocytic ... Myelodysplastic... | vosaroxin | 60 Years - | Sunesis Pharmaceuticals | |
| Role of Intraoperative Ultrasound in Gastrointestinal (GI) Malignancies | NCT01143922 | Ultrasonography Gastrointestina... Malignancy | 10 Years - 90 Years | All India Institute of Medical Sciences, New Delhi | ||
| Efficacy of Apixaban in Malignancy With Deep Venous Thrombosis | NCT04462003 | Deep Vein Throm... Malignancy | Apixaban Enoxaparin | 20 Years - 80 Years | Beni-Suef University | |
| Platelet Modulation: A Study of Angiogenic and Coagulation Proteins in Patients With Cancer | NCT01148407 | Cancer | 18 Years - | University of Vermont | ||
| The Effect of Epidural Fentanyl on Immune Function | NCT01646775 | Malignancy | epidural fentan... | 18 Years - | McGill University Health Centre/Research Institute of the McGill University Health Centre | |
| One Week Parathyroid Hormone-related Protein (PTHrP) IV Dose Escalation Study | NCT00580788 | Osteoporosis Humoral Hyperca... Hyperparathyroi... | PTHrP (1-36) | 24 Years - 35 Years | University of Pittsburgh | |
| HemosprayTM for Gastrointestinal Bleeding From Cancer | NCT03855904 | Gastrointestina... | TC-325 | 18 Years - | King Chulalongkorn Memorial Hospital | |
| Safety and Efficacy of Marqibo in Relapsed Acute Lymphoblastic Leukemia | NCT00495079 | Acute Lymphobla... | Marqibo® (vincr... | 18 Years - | Spectrum Pharmaceuticals, Inc | |
| A Randomized Phase II Study of Oral Thalidomide in Patients With Hormone-Refractory Prostate Cancer | NCT00001446 | Prostatic Neopl... | thalidomide | - | National Institutes of Health Clinical Center (CC) | |
| BostonGene-Integrated Genomic Registry (BIGR) | NCT04991922 | Malignancy | 18 Years - | BostonGene | ||
| Liquid Biopsy With Immunomagnetic Beads Capture Technique for Malignant Cell Detection in Body Fluid | NCT02891642 | Malignancy Pleural Effusio... Pleural Disease... Ascites | Immunomagnetic ... | 18 Years - 80 Years | The First Affiliated Hospital with Nanjing Medical University | |
| Safety and Efficacy Study of ALT-801 to Treat Progressive Metastatic Malignancies | NCT00496860 | Progressive Met... | ALT-801 | 18 Years - | Altor BioScience | |
| Comparison of Criteria for Liver Transplantation in Hepatocellular Carcinoma | NCT04576572 | Hepatocellular ... Liver Cancer Advanced Adult ... Cirrhosis, Live... Unresectable Li... Liver Transplan... | - | Inonu University | ||
| DETERMINE Trial Treatment Arm 03: Entrectinib in Adult, Teenage/Young Adults and Paediatric Patients With ROS1 Gene Fusion-positive Cancers. | NCT05770544 | Solid Tumor Haematological ... Malignancy Malignant Neopl... Lymphoprolifera... Neoplasms by Hi... Neoplasms by Si... Cancer Brain Neoplasms Melanoma Glioma | Entrectinib | - | Cancer Research UK | |
| A Study to Evaluate the Safety, Pharmacokinetics, and Antitumor Activity of AK114 | NCT05200273 | Advanced or Met... Malignancy Metastasis | AK114 | 18 Years - | Akeso | |
| Community Health Worker Based Intervention to Improve Palliative Care | NCT05407844 | Cancer End Stage Cance... Malignancy Advanced Cancer | Community Healt... | 18 Years - | Johns Hopkins University | |
| Safety Study of Intratumoral Injection of Clostridium Novyi-NT Spores to Treat Patients With Solid Tumors That Have Not Responded to Standard Therapies | NCT01924689 | Solid Tumor Mal... | Clostridium nov... | 18 Years - | BioMed Valley Discoveries, Inc | |
| Study of PD/PK/PG Relationships of Tacrolimus and Cyclosporin in Liver Transplant Patients | NCT01760356 | End Stage Liver... Rejection Infection Malignancy Toxicity Diabetes | 18 Years - 70 Years | UDA Centro Nacional Hepato-Bilio-Pancreático | ||
| A Clinical Study of Anti-CD19 Chimeric Antigen Receptor T-Cell Injection (CNCT19) in the Treatment of Cluster of Differentiation 19 (CD19) Positive Relapsed or Refractory B Cell Malignancies | NCT04011293 | Relapsed or Ref... | CNCT19 | 18 Years - | Shandong University | |
| Safety and Efficacy of Marqibo in Relapsed Acute Lymphoblastic Leukemia | NCT00495079 | Acute Lymphobla... | Marqibo® (vincr... | 18 Years - | Spectrum Pharmaceuticals, Inc | |
| Outcomes of Transcatheter Aortic Valve Implantation in Oncology Patients With Severe Aortic Stenosis | NCT03181997 | Aortic Valve St... Malignancy | Native aortic v... Transcatheter a... | - | Rabin Medical Center | |
| A Study to Compare CAELYX With Topotecan HCL in Patients With Recurrent Epithelial Ovarian Carcinoma Following Failure of First-Line, Platinum-Based Chemotherapy | NCT01840943 | Epithelial Ovar... | CAELYX Topotecan HCl | 18 Years - | Xian-Janssen Pharmaceutical Ltd. | |
| Comparison of Translocator Protein Expression and Binding Activity in Normal Tissue Versus Non Melanotic Malignancy | NCT01265472 | Squamous Cell C... Basal Cell Carc... | - | Rambam Health Care Campus | ||
| Skull Base and Low Grade Glioma Neurocognitive Magnetic Resonance Imaging (MRI) Study | NCT01212731 | Malignancy Glioma Radiotherapy | Photon treatmen... Proton Treatmen... Neurocognitive ... Advanced MRI im... | 18 Years - | Abramson Cancer Center at Penn Medicine | |
| A Study for Participants Previously Treated With Century Therapeutics Cellular Therapy Product | NCT05768269 | Hematological M... Solid Tumor Mal... | No Intervention | 18 Years - | Century Therapeutics, Inc. | |
| Role of Intraoperative Ultrasound in Gastrointestinal (GI) Malignancies | NCT01143922 | Ultrasonography Gastrointestina... Malignancy | 10 Years - 90 Years | All India Institute of Medical Sciences, New Delhi | ||
| Same-session MR-only Simulation and Treatment With MRI-guided Adaptive Palliative RadioTherapy | NCT03824366 | Malignancy Metastasis Hemoptysis Gastrointestina... Pelvic Bleeding Superior Vena C... Mediastinal Dis... | Volumetric MR i... Radiation thera... | 18 Years - | Washington University School of Medicine | |
| Monitoring HDR Brachytherapy for Cervical Cancer by Optic and Thermal Imaging | NCT02818179 | MALIGNANCY | THERMOGRAPHY IM... | 18 Years - 90 Years | Sheba Medical Center | |
| Collection of Blood, Bone Marrow, Tumor or Tissue Samples | NCT00043615 | Neoplasms Precancerous Co... | 18 Years - | National Institutes of Health Clinical Center (CC) | ||
| Esophagectomy for Patients With Esophageal Cancer and Cervical Lymph Node Metastases | NCT02426879 | Cancer Squamous Cell C... Adenocarcinoma Malignancy | esophagectomy w... | 18 Years - 99 Years | UMC Utrecht | |
| Obstruction of Malignancy: Percutaneous Renal vs Endoscopic Stent | NCT05640115 | Cancer Urinary Obstruc... Malignancy Urinary Dysfunc... Ureter Obstruct... Ureter Injury | Ureteral Stent Percutaneous Ne... | 18 Years - | University of Chicago | |
| A Trial of RSC-1255 for Treatment of Patients With Advanced Malignancies | NCT04678648 | Advanced Malign... RAS Mutation Lung Cancer Colon Cancer Glioblastoma Pancreatic Canc... | RSC-1255 Dose E... RSC-1255 Dose E... | 18 Years - | RasCal Therapeutics, Inc. | |
| HemosprayTM for Gastrointestinal Bleeding From Cancer | NCT03855904 | Gastrointestina... | TC-325 | 18 Years - | King Chulalongkorn Memorial Hospital | |
| Thyroid Cancer in United Arab Emirates | NCT04763122 | Thyroid Cancer | not applicable ... | - | Tawam Hospital | |
| Return to Work Among Cancer Survivors With Treatment-induced Survivorship Syndromes | NCT03961217 | Gynecologic Can... Prostate Cancer Radiation Toxic... Malignancy Radiotherapy Si... Radiation Injur... Cancer Survivor... Radiation Syndr... | Radiotherapy | 25 Years - 60 Years | Sahlgrenska University Hospital, Sweden | |
| A Case Series on Incidentally Detected Gallbladder Malignancy | NCT05606029 | Gallbladder Mal... | Cholecystectomy... | 18 Years - 70 Years | Osmania Medical College | |
| Study of the Safety and Pharmacokinetics of Olaratumab (IMC-3G3) in Japanese Participants With Solid Tumors | NCT01199822 | Malignancy Metastasis | Olaratumab | 20 Years - | Eli Lilly and Company | |
| Virotherapy and Natural History Study of KHSV-Associated Multricentric Castleman s Disease With Correlates of Disease Activity | NCT00092222 | Lymphoprolifera... HHV-8 Malignancy HIV | Etoposide Interferon-alph... Rituximab Zidovudine Liposomal Doxor... Bortezomib Valganciclovir Doxorubicin Vincristine Cyclophosphamid... Filgrastim (G-C... Prednisone Sirolimus Observation Onl... | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| The Role of the EKG in Anticancer Drug Development | NCT01462383 | Advanced Cancer | - | M.D. Anderson Cancer Center | ||
| Self-Administered Nitrous Oxide (SANO) During Transrectal Prostate Biopsy to Reduce Patient Anxiety and Pain | NCT05803096 | Prostate Diseas... Malignancy Benign Prostati... Prostate Cancer Prostate Adenoc... Anxiety and Fea... Pain | Self-Administer... Oxygen | 18 Years - 85 Years | Beth Israel Deaconess Medical Center | |
| Study of Ponatinib in Patients With Lung Cancer Preselected Using Different Candidate Predictive Biomarkers | NCT01935336 | Adenocarcinoma ... Extensive Stage... Limited Stage S... Recurrent Non-s... Recurrent Small... Stage IIIA Non-... Stage IIIB Non-... Stage IV Non-sm... | Ponatinib | 18 Years - | University of Colorado, Denver | |
| Study of Quizartinib in Japanese Patients With Newly Diagnosed Acute Myeloid Leukemia (AML) | NCT02834390 | Acute Myeloid L... | Quizartinib Cytarabine Idarubicin Daunorubicin | 20 Years - 75 Years | Daiichi Sankyo | |
| Does Transcranial Magnetic Stimulation of the Cingulate Cortex Modulate the Perception of Dyspnoea? | NCT00830921 | Malignancy | Transcranial Ma... | 18 Years - | University of Oxford | |
| The Effect of Epidural Fentanyl on Immune Function | NCT01646775 | Malignancy | epidural fentan... | 18 Years - | McGill University Health Centre/Research Institute of the McGill University Health Centre | |
| Dose Escalation Study of Safety and Tolerability of AT-406 in Patients With Advanced Solid Tumors and Lymphomas | NCT01078649 | Cancer Solid Tumors Lymphoma Malignancy | Debio 1143 (AT-... | 18 Years - | Debiopharm International SA | |
| Malignancy Meta Analysis for BRL49653 | NCT01195259 | Diabetes Mellit... | allocation of t... | - | GlaxoSmithKline | |
| Ultrasound-Guided Needle Biopsy in the Diagnosis of Malignant Cervical Lymphadenopathies | NCT01384357 | Lymphadenopathy Malignancy | 20 Years - 85 Years | Far Eastern Memorial Hospital | ||
| A Dose Escalation Study of OMP-54F28 in Subjects With Solid Tumors | NCT01608867 | Solid Tumors | OMP-54F28 | 18 Years - 90 Years | Mereo BioPharma | |
| HemosprayTM for Gastrointestinal Bleeding From Cancer | NCT03855904 | Gastrointestina... | TC-325 | 18 Years - | King Chulalongkorn Memorial Hospital | |
| Genetic Exploration of the Molecular Basis of Malignancy in Adults | NCT02416518 | Neoplasms | 18 Years - | Sanford Health | ||
| Safety Assessment of Two Schedules of Intravenous Infusions of SNS-595 for the Treatment of Hematologic Malignancies | NCT00246662 | Leukemia, Lymph... Leukemia, Nonly... Leukemia, Myelo... Myelodysplastic... | Vosaroxin | 18 Years - | Sunesis Pharmaceuticals | |
| NP2 Enkephalin For Treatment of Intractable Cancer Pain | NCT01291901 | Intractable Pai... Neoplasms | NP2 Placebo | 18 Years - | Diamyd Inc | |
| A Study to Compare CAELYX With Topotecan HCL in Patients With Recurrent Epithelial Ovarian Carcinoma Following Failure of First-Line, Platinum-Based Chemotherapy | NCT01840943 | Epithelial Ovar... | CAELYX Topotecan HCl | 18 Years - | Xian-Janssen Pharmaceutical Ltd. |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
